esketamine
Articles tagged with “esketamine”
FDA Esketamine (Spravato) Updates
A summary of the latest FDA regulatory actions, label updates, and clinical developments related to esketamine (Spravato) for depression treatment.
Racemic Ketamine vs Esketamine: Pharmacological Comparison
A detailed pharmacological comparison of racemic ketamine and esketamine (Spravato), covering efficacy, mechanisms, cost, access, and clinical decision-making.
Intranasal Ketamine and Esketamine (Spravato)
A comprehensive guide to intranasal ketamine therapy, including the FDA-approved esketamine nasal spray Spravato — how it works, the REMS program, and clinical considerations.
Racemic Mixture: S-Ketamine and R-Ketamine Enantiomers Explained
A definition of racemic mixture in the context of ketamine therapy — explaining the S and R enantiomers, their different pharmacological profiles, and clinical implications.
Esketamine: The S-Enantiomer Behind Spravato
A glossary entry on esketamine, the S-enantiomer of ketamine marketed as Spravato, covering its pharmacology, FDA approval, and clinical significance.
Enantiomer: Definition and Relevance to Ketamine
A definition of enantiomers — mirror-image molecular forms — and their critical importance in understanding ketamine's two forms: esketamine (S-ketamine) and arketamine (R-ketamine).
Esketamine vs Racemic Ketamine: Understanding the Difference
A clinical comparison of esketamine (Spravato) and racemic ketamine, covering the S-enantiomer vs R/S mixture, FDA approval, efficacy data, cost, and practical considerations.
Ready to learn more?
Explore our comprehensive guides and tools to help you navigate your ketamine therapy journey.